Check the statistics ;there is a higher mortality rate for those with the lowest cholesterol level . Cholesterol does NOT cause heart disease .Inflammation causes heart attacks. I would never ever take a statin drug.
I agree. I have had type1 for over 40 years, refused statins. I tke 2 1000 milligram Omega -3 tablets a day. My cholesterol is optimum and my c-reactive protein test, a marker for inflamation in the body, is rated as optimal. hence, I refused statins: Tried zocor and lipitor, they gave me bad side effects, muscle pains and low blood pressure. So I said no to statins 3 years ago after a trial period and being told I needed to be have an LDL below 70 ( I can stay between 66 and 80 without statins.
There was a past discussion about the use of statins on this forum, from several months, maybe even a year ago.
Thre consesnsus seemed to be that the effects are vaiable among the type 1 population. I personally avoid them and am no worse the wear. But then as Joe noted, it is the inflammation we need to control. as I said above I requested a co- reactive protein test and as I noted mine was .02, which is optimum.So definitely no statins for me.
I do not understand the requirement to be under 70. On my lab results, it says specifically, that under 100 is OK for diabetics if the person does not have existing CVD. The target of 70 is for persons with diabetes WHO DO HAVE CDV.
Brunetta, i am on traqck with all you suggested. My CRP is fine. I think these docs try to cover their butts sometimes and get caught up in the drug consciousness. They are surrounded by it. I just hoped my doc was a bove that.
I was on lipitor for years this was before dx of type 2. I started taking Lipitor when it was a tier 1 prescription. My ENDO changed me over to Crestor and I saw a 20 to 30 point drop in my total Cholesterol. I never saw any side effects except in the wallet
Grant given to support programs aimed at bringing together people touched by diabetes for positive change BERKELEY, CA: December 4, 2014 – Diabetes Hands Foundation (DHF) has received a grant of US$200,000 from Novo Nordisk to support programs aimed at Read on! →
At Symplur we track hashtags, keywords, user accounts, and pretty much anything else on Twitter that has to do with healthcare. We collect the data and then build countless ways to slice it up so that we’re able to better Read on! →